Anna Wawruszak

1.5k total citations · 1 hit paper
49 papers, 1.1k citations indexed

About

Anna Wawruszak is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, Anna Wawruszak has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Plant Science. Recurrent topics in Anna Wawruszak's work include Histone Deacetylase Inhibitors Research (13 papers), Epigenetics and DNA Methylation (12 papers) and Sirtuins and Resveratrol in Medicine (4 papers). Anna Wawruszak is often cited by papers focused on Histone Deacetylase Inhibitors Research (13 papers), Epigenetics and DNA Methylation (12 papers) and Sirtuins and Resveratrol in Medicine (4 papers). Anna Wawruszak collaborates with scholars based in Poland, Finland and Greece. Anna Wawruszak's co-authors include Andrzej Stepulak, Marta Hałasa, Estera Okoń, Wirginia Kukuła‐Koch, Karolina Okła, Arkadiusz Czerwonka, Jarogniew J. Łuszczki, Jan Kotarski, Magdalena Dmoszyńska‐Graniczka and Iwona Wertel and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Anna Wawruszak

45 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phytosterols: From Preclinical Evidence to Potential Clinical Applications

2021 218 citations Wirginia Kukuła‐Koch, Anna Wawruszak et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Wawruszak Poland	18	586	283	164	106	86	49	1.1k
Paola De Cicco Italy	20	472 0.8×	327 1.2×	290 1.8×	115 1.1×	152 1.8×	26	1.3k
Do Youn Jun South Korea	19	600 1.0×	165 0.6×	126 0.8×	116 1.1×	116 1.3×	58	1.0k
J. K. Kundu South Korea	8	364 0.6×	174 0.6×	165 1.0×	105 1.0×	148 1.7×	10	866
Sung‐Moo Kim South Korea	20	525 0.9×	205 0.7×	76 0.5×	188 1.8×	118 1.4×	33	1.2k
Ji‐Ye Kee South Korea	18	460 0.8×	163 0.6×	165 1.0×	90 0.8×	133 1.5×	37	901
Anna L. Greenshields Canada	16	550 0.9×	159 0.6×	94 0.6×	56 0.5×	162 1.9×	41	1.2k
Shin‐Hyung Park South Korea	19	557 1.0×	162 0.6×	104 0.6×	104 1.0×	130 1.5×	57	1.1k
Anuradha Sehrawat United States	22	607 1.0×	137 0.5×	85 0.5×	107 1.0×	90 1.0×	46	1.1k
Eliana Guerriero Italy	21	472 0.8×	187 0.7×	146 0.9×	58 0.5×	150 1.7×	35	1.2k

Countries citing papers authored by Anna Wawruszak

Since Specialization

Citations

This map shows the geographic impact of Anna Wawruszak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Wawruszak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Wawruszak more than expected).

Fields of papers citing papers by Anna Wawruszak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Wawruszak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Wawruszak. The network helps show where Anna Wawruszak may publish in the future.

Co-authorship network of co-authors of Anna Wawruszak

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Wawruszak. A scholar is included among the top collaborators of Anna Wawruszak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Wawruszak. Anna Wawruszak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Okoń, Estera, et al.. (2025). Chemopreventive and Anticancer Activity of Selected Triterpenoids in Melanoma. Cancers. 17(10). 1625–1625.

Okoń, Estera, et al.. (2024). The Activity of 1,8-Dihydroanthraquinone Derivatives in Nervous System Cancers. Molecules. 29(24). 5989–5989.

Kukuła‐Koch, Wirginia, Estera Okoń, Anna Wawruszak, et al.. (2024). Vaccinium Species—Unexplored Sources of Active Constituents for Cosmeceuticals. Biomolecules. 14(9). 1110–1110. 5 indexed citations

Koch, Wojciech, et al.. (2024). Plant Phenolics in the Prevention and Therapy of Acne: A Comprehensive Review. Molecules. 29(17). 4234–4234. 12 indexed citations

Wawruszak, Anna, Apostolis Angelis, Arkadiusz Czerwonka, et al.. (2023). High-throughput isolation of gentiopicroside from Gentiana lutea and the study on its anticancer properties in vitro. Industrial Crops and Products. 195. 116448–116448. 2 indexed citations

Wawruszak, Anna, et al.. (2023). A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identification and Drug Targeting, and Developments in Personalized Medicine in Breast Cancer. Medical Science Monitor. 29. e940550–e940550. 4 indexed citations

Okoń, Estera, et al.. (2023). Therapeutic Potential of 1,8-Dihydroanthraquinone Derivatives for Breast Cancer. International Journal of Molecular Sciences. 24(21). 15789–15789. 4 indexed citations

Bartnik, Magdalena, Apostolis Angelis, Anna Wawruszak, et al.. (2023). Gentiopicroside—An Insight into Its Pharmacological Significance and Future Perspectives. Cells. 13(1). 70–70. 11 indexed citations

Okoń, Estera, Anna Wawruszak, Adrianna Sławińska-Brych, et al.. (2023). Emodin-8-O-Glucoside—Isolation and the Screening of the Anticancer Potential against the Nervous System Tumors. Molecules. 28(21). 7366–7366. 4 indexed citations

10.

Kędzierawski, Piotr, Janusz Kopczyński, Anna Wawruszak, et al.. (2023). Kaiso Protein Expression Correlates with Overall Survival in TNBC Patients. Journal of Clinical Medicine. 12(1). 370–370. 1 indexed citations

11.

Wawruszak, Anna, Jarogniew J. Łuszczki, Estera Okoń, Arkadiusz Czerwonka, & Andrzej Stepulak. (2022). Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis. International Journal of Molecular Sciences. 23(12). 6458–6458. 7 indexed citations

12.

Wawruszak, Anna, Jarogniew J. Łuszczki, Arkadiusz Czerwonka, Estera Okoń, & Andrzej Stepulak. (2022). Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells. Cells. 11(7). 1211–1211. 18 indexed citations

13.

Wawruszak, Anna, et al.. (2021). Vorinostat (SAHA) and Breast Cancer: An Overview. Cancers. 13(18). 4700–4700. 79 indexed citations

14.

Wawruszak, Anna, Jarogniew J. Łuszczki, Marta Hałasa, et al.. (2021). Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together. International Journal of Molecular Sciences. 22(10). 5184–5184. 7 indexed citations

15.

Okoń, Estera, Jarogniew J. Łuszczki, Wirginia Kukuła‐Koch, et al.. (2020). Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin. International Journal of Molecular Sciences. 21(8). 2848–2848. 18 indexed citations

16.

Okoń, Estera, Wirginia Kukuła‐Koch, Marta Hałasa, et al.. (2020). Magnoflorine—Isolation and the Anticancer Potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 Rhabdomyosarcoma Cancer Cells. Biomolecules. 10(11). 1532–1532. 30 indexed citations

17.

Wawruszak, Anna, Estera Okoń, Witold Jeleniewicz, et al.. (2019). <p>Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties</p>. Cancer Management and Research. Volume 11. 8345–8358. 17 indexed citations

18.

Wawruszak, Anna, Jarogniew J. Łuszczki, Joanna Kałafut, et al.. (2019). Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis. International Journal of Molecular Sciences. 20(15). 3663–3663. 17 indexed citations

19.

Wawruszak, Anna, Joanna Kałafut, Estera Okoń, et al.. (2019). Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells. Cancers. 11(2). 148–148. 85 indexed citations

20.

Bobiński, Marcin, Karolina Okła, Wiesława Bednarek, et al.. (2019). The Effect of Fucoidan, a Potential New, Natural, Anti-Neoplastic Agent on Uterine Sarcomas and Carcinosarcoma Cell Lines: ENITEC Collaborative Study. Archivum Immunologiae et Therapiae Experimentalis. 67(2). 125–131. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact